Manufacturer record
Aagya Biotech Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
7 batches manufactured by Aagya Biotech Pvt. Ltd (Uttarakhand) were declared Not of Standard Quality between March 2019 and June 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: T-2506151, Mefenamic Acid Tablets B.P. 500 mg, (exp May 2027). RDTL Ernakulam (state lab) found it not of standard quality: The Sample does not confirms to BP standards with respect to the test Disintegration. Listed in the June 2026 alert.
Records by type
7 records linked to Aagya Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Mefenamic Acid Tablets B.P. 500 mg, | Batch T-2506151Mfg Jun 2025 · Exp May 2027 | The Sample does not confirms to BP standards with respect to the test DisintegrationDisintegration | RDTL ErnakulamState lab | Jun 2026 |
| Paracetamol Tablets IP 500 mg | Batch GAB2566Mfg Nov 2023 · Exp Oct 2026 | DescriptionDescription | SDT&RL, BhubaneswarState lab | May 2026 |
| Ofloxacin and Ornidazole tablets IP (Oflacin-OZ) | Batch T-2406084Mfg Jun 2024 · Exp May 2027 | DescriptionDescription | State Drugs Laboratory, PunjabState lab | Jul 2025 |
| Aceclofenac & Paracetamol Tablets (Aceflam P) | Batch T-2403035Mfg Mar 2024 · Exp Feb 2027 | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform as per IP 2022 with respect to Description.Description | State Lab PuducherryState lab | Apr 2025 |
| Folic Acid Tablets IP 5 mg (FOLITAS) | Batch T-2406004Mfg Jun 2024 · Exp May 2026 | "Hydrolysis products (N-(4- aminobenzoyl)- L-Glutamic acid)"Other | CDTL MumbaiCDSCO lab | Nov 2024 |
| Ornizole (Ornidazole Tablets I.P. 500 mg) | Batch T-1710151Mfg Oct 2017 · Exp Sep 2019 | DescriptionDescription | CDL KolkataCDSCO lab | Aug 2019 |
| AMOXYCILLIN & DICLOXACILLIN CAPSULES (ELMOX-PLUS) | Batch AB7003Mfg May 2017 · Exp Apr 2019 | Physical ParameterOther | RDTL GuwahatiState lab | Mar 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.